TITLE

Abstract

PUB. DATE
April 2007
SOURCE
Gut;Apr2007 Supplement 2, Vol. 56, pA1
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
The article presents abstracts of medical research. They include "The use of adalimumab in refractory crohn's disease: a tertiary referral centre experience," "Infliximab as rescue therapy in acute severe ulcerative colitis: a survey of the Scottish society of gastroenterology," and "Hepatitis E in southwest England."
ACCESSION #
24572045

 

Related Articles

  • Journal Scan.  // Gut;Dec2003, Vol. 52 Issue 12, p1796 

    The article presents glimpses of several articles that are published in different journals. The article "Impact of Liver Biopsy Size on Histological Education of chronic Viral Hepatitis: The Smaller the Sample, the Milder the Disease," describes that live

  • The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population.  // BMC Gastroenterology;2011, Vol. 11 Issue 1, p83 

    The article examines the prevalence of Primary sclerosing cholangitis (PSC), a rare chronic cholestatic liver disease often associated inflammatory bowel diseases (IBD) in a large, ethnically diverse U.S. population. It is given that around 101 males with a mean age at diagnosis of 44 years were...

  • Prevalence and Factors Related to Hepatitis B and C in Inflammatory Bowel Disease Patients in Spain: A Nationwide, Multicenter Study. Loras, Carme; Saro, Cristina; Gonzalez-Huix, Ferràn; Mínguez, Miguel; Merino, Olga; Gisbert, Javier P.; Barrio, Jesús; Bernal, Antonio; Gutiérrez, Ana; Piqueras, Marta; Calvet, Xavier; Andreu, Montserrat; Abad, Agueda; Ginard, Daniel; Bujanda, Luis; Panés, Julián; Torres, Miquel; Fernéndez-Bañares, Fernando; Viver, Josep M.; Esteve, Maria // American Journal of Gastroenterology;Jan2009, Vol. 104 Issue 1, p57 

    OBJECTIVES: Limited information suggests the existence of a high prevalence of hepatitis B (HBV) and C virus (HCV) infection in inflammatory bowel disease (IBD). This knowledge is relevant because the viruses may reactivate under immunosuppressive therapy. The objectives of this study are to...

  • Liver dysfunction in inflammatory bowel disease.  // British Medical Journal;9/22/1979, Vol. 2 Issue 6192, p688 

    Examines the association between hepatobiliary disorders and inflammatory bowel disease in Birmingham, England. List of abnormalities; Dependence of the prevalence of minor histological abnormalities on the source of the pathological material; Effect of colectomy on the liver.

  • Thioguanin-induced nodular regenerative hyperplasia of the liver-ROC analysis of different MR techniques. Zech, Christoph J.; Seiderer, Julia; Reinisch, Walter; Ochsenkuhn, Thomas; Schima, Wolfgang; Diebold, Joachim; Wrba, Fritz; Reiser, Maximilian F.; Schoenberg, Stefan O. // European Radiology;Jul2007, Vol. 17 Issue 7, p1898 

    The aim of this study was to evaluate the diagnostic value of different magnetic resonance (MR) techniques for the diagnosis of nodular regenerative hyperplasia (NRH). Thirty-one patients with inflammatory bowel disease, who received 6-thioguanin, underwent liver biopsy and liver MRI on a 1.5-T...

  • Thiopurine-Induced Liver Injury in Patients With Inflammatory Bowel Disease: A Systematic Review. Gisbert, Javier P.; González-Lama, Yago; Maté, José // American Journal of Gastroenterology;Jul2007, Vol. 102 Issue 7, p1518 

    The mean prevalence of azathioprine (AZA) or 6-mercaptopurine (MP)-induced liver injury in patients with inflammatory bowel disease was approximately 3%, and the mean annual drug-induced liver disorder rate was only 1.4%. However, this low figure calculated from retrospective studies contrasts...

  • Manchester University heads £10m EU-funded research network into inflammatory bowel disease.  // Gastrointestinal Nursing;Apr2013, Vol. 11 Issue 3, p6 

    The article reports that the University of Manchester is leading a 10 million Sterling Pound, 5-year research network to identify better treatments for inflammatory bowel diseases (IBD), such as Crohn's disease (CD) and ulcerative colitis (UC).

  • GI highlights from the literature. McLean, Mairi H. // Gut;Oct2014, Vol. 63 Issue 10, p1677 

    The article presents abstracts on medical topics which include the role of TH9 cells in inflammatory bowel disease, link of mutations and cancer in benign Barrett's oesophagus, and role of periostin in the pathogenesis of obesity-induced liver disease.

  • Hepatitis A, B, G cases drop dramatically over 10 years.  // East Bernard Express (TX);3/22/2007, Vol. 64 Issue 12, p5 

    The article reports that Hepatitis A, B, C cases in the U.S. drop dramatically over 10 years, between 1995 and 2005, according to the Center for Disease Control and Prevention.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics